Ledger.Open graph →
SEC Form D · filed November 16, 2023

EvolveImmune Therapeutics Holding Company, LLC

Offering
$57.4M
Sold
$37.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Branford, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Denis Patrick · New City, NYDirectorAlessandra Di Bacco · Cambridge, MADirectorIan Taylor · Madison, CTDirectorSeth Wolkov · Denver, CODirectorJason W. Lettmann · Menlo Park, CADirectorAndrew Arsht · WASHINGTON, Washington, D.C.Exec · DirectorGordon Stebbings · DeForest, WIExec · DirectorStephen Bloch · Branford, CTExec · DirectorDerek Yoon · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗